From a clinical perspective, carriers of FH variants are at least at a 3-fold increased risk of CAD, and given that they remain underdiagnosed and undertreated, there is an opportunity for targeted intervention to promote adherence to healthy lifestyle measures. The gene discussed is FH; the disease is coronary artery disorder.